When Stein & Leventhal (1935) first wrote of this syndrome they described a group of women who had in common infertility, oligomenorrhoea or amenorrhoea and enlarged polycystic ovaries.
Other frequent but not invariable findings were hirsutism, obesity and, less frequently, clitoral hypertrophy. These symptoms and signs are not peculiar to the polycystic ovary. Infertility, menstrual irregularity and hirsutism are such common individual symptoms in women attending a gynwecological endocrine clinic that they will appear together more often from chance association than from the Stein-Leventhal syndrome. Similar clinical features may also be found in patients with virilizing adrenal hyperplasia. Furthermore, ovarian changes indentical to this described by Stein & Leventhal have been found in patients with gross adrenocortical hyperfunction (Abu-Haydar et al. 1954 , Philipp & Stange 1954 , Perloff et al. 1958 ) although these few examples are the exception rather than the rule (Jones & Jones 1954) . While the macroscopic appearance of the ovaries is characteristic, the microscopic changes described by Stein & Leventhal are not specific for the polycystic ovary (Roberts & Haines 1960 , Green & Goldzieher 1965 ).
There is very real difficulty in the clinical diffefential diagnosis of this syndrome -difficulty not dissimilar to that presented to the clinician when unravelling a problem of adrenal hyperplasia: clinical and pathological expertise are not, by themselves, enough; if treatment is to have a high prospect of success, clinical suspicion must be augmented by selective hormone assays.
Hormone Assays
The perplexing hormonal environment of these patients has been reviewed recently (Shearman & Cox 1966 ). Studies of cyst fluid and excised ovarian tissue have helped considerably in an understanding of the biochemical complexities of this syndrome but clearly are of no assistance in a pre-operative assessment. Urinary 17-ketosteroids, pregnanediol and pregnanetriol are within the normal range , Shearman & Cox 1965 , Goldzieher & Axelrod 1962 , Lanthier & Sandor 1960 . Estimation of individual 17-ketosteroids, although sometimes yielding information of interest (Perloff et al. 1958 , Gallagher et al. 1958 , Baulieu et al. 1963 , Mahesh & Greenblatt 1961 , 1964b , rarely provides answers of clinical value. Urinary cestrogen levels are usually similar to those found in the follicular phase of the normal cycle before the rise to the ovulation peak , Shearman & Cox 1965 , Brown & Matthew 1962 , Giorgi 1963 , Mahesh & Greenblatt 1964b ) although increased levels may be found in association with endometrial hyperplasia (Shearman & Cox 1965) . The level of plasma testosterone is usually increased (Dignam et al. 1964 , Forchielli et al. 1963 , Simmer 1963 . This provides chemical confirmation of the clinical fact of androgenization but does not help to determine the site of abnormal production and/or conversion.
Two investigations have proved to be of value in diagnosis: these are the urinary levels of A5-pregnenetriol and pregnanetriolone and the effect of diagnostic gonadotrophin stimulation on ovarian size and urinary oestrogens. A5-pregnenetriol and pregnanetriolone: A5-pregnenetriol (pregn-5-ene-3,, 17a, 20ca-triol) is a unique metabolite of 17-hydroxypregnenolone. Cox found increased urinary excretion in pre-operative studies of patients with the Stein-Leventhal syndrome and similar find-ings were reported by Stern & Barwell (1963) . However, Wilson et al. (1961) found normal levels and Mahesh & Greenblatt (1964b) could demonstrate increased excretion only after gonadotrophin stimulation. The clinical usefulness of this assay in these circumstances is therefore not established.
Pregnanetriolone (3a, 17a, 20ac-trihydroxy-5p-pregnan-11 -one) was detected in the urine of 31 of 33 patients with polycystic ovaries , Shearman & Cox 1966 ), a finding confirmed by Finkelstein (1962) and Leventhal & Scommegna (1963) . This observation is of clinical value, since this compound is not normally detectable in urine and has been found otherwise only in the urine of individuals suffering from adrenal hyperplasia associated with either the adrenogenital syndrome or Cushing's disease (Cox 1960 , Finkelstein 1959 20-40 ,ug/24 h (Finkelstein 1962) , although useful in adrenal hyperplasia, are not really suitable for the patient with polycystic ovaries as the level excreted is often below this limit of sensitivity (Shearman & Cox 1965) . This test will be more useful when specific convenient methods with a sensitivity of 5-10 pg/24 h are available.
Response to gonadotrophins: In 1957 Keettel et al. showed that the majority of women with polycystic ovaries develop gross ovarian enlargement after stimulation with hog or sheep FSH whereas this did not occur in patients with other types of amenorrhmea. There is general agreement on the morphological change whether the gonadotrophin used be homologous (Crooke et al. 1963 , Greenblatt 1963 or heterologous (Shearman 1964) . Both Gemzell and Crooke (Gemzell et al. 1960 , Crooke et al. 1963 showed that this ovarian response was accompanied by a marked increase in excretion of urinary cestrogens. Using a heterologous preparation (pregnant mares serum gonadotrophin) in a standardized gonadotrophin stimulation test Shearman (1964 , Shearman & Cox 1966 ) described an exaggerated increase in urinary cestrogens in subjects with polycystic ovaries. This very large increase in urinary cestrogens does not occur in patients with other types of amenorrhoea when exposed to the same stimulus (Shearman 1964 The response of the second patient is quite different (Fig 2) The urinary excretion of steroids: Fractionation and individual estimation of steroid excretion patterns was carried out in 45 hirsute women with varying degrees of menstrual failure (Mahesh & Greenblatt 1964) . Thirty-one women were found to have elevations in one or more of the 17-ketosteroid fractions whereas in 14 women the levels of steroid excretion were well within the normal range. Sixteen women had elevations in the 1 1-oxygenated-17-ketosteroid fraction with or without a similar elevation in 11-deoxy-17-ketosteroids; as 1 1-oxygenated-17-ketosteroids, with very rare exceptions, are metabolites of compounds of adrenal origin, the adrenals appear to be implicated in these patients. This observation is supported by the satisfactory suppression of the elevated levels of steroids on dexamethasone administration (Mahesh et al. 1964) .
The remaining 15 patients had elevated levels of 1 1-deoxy-17-ketosteroids and consisted mainly of patients with the Stein-Leventhal syndrome. Routine determination of total 17-ketosteroids in these patients showed only normal to slightly elevated levels and significant elevations were noted only after fractionation and individual estimation of various steroids. The patients could be divided into two groups based on their response to adrenal suppression. Five patients showed good depression of urinary 1 1-deoxy-17-ketosteroids as compared to the normal when the
